Analysis of tumor samples showed a low frequency of anti-c-kit antibody immunoreactivity in primary neuroblastoma tumors or ganglioneuromas and a variable immunoreactivity in metastatic samples; besides, no coexpression of c-kit and SCF was observed. This evidence concerns the gene KITLG and neoplasm.